ALYSSA FILLIBEN: Open Payments
NPI 1235653833 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 20 payments from 9 companies in 2025. Trend: 2023 $622 · 2024 $878 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| Cleerly, Inc. | 8 | $185 |
| Medtronic, Inc. | 1 | $101 |
| PFIZER INC. | 4 | $90 |
| Boston Scientific Corporation | 2 | $53 |
| ABIOMED | 1 | $36 |
| BridgeBio Pharma, Inc. | 1 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $28 |
| Kestra Medical Technology Services, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: Cleerly Ischemia, COREVALVE EVOLUT R, WATCHMAN FLX, ELIQUIS, VYNDAQEL, Attruby, Kerendia, Assure WCD.
Industry payments across FL — which companies pay providers there.
